1. Maxim Cherkashin,
PhD Student,
Chmn (at) nxt.ru
www.bmt.bmstu.ru
Chair for Medico-Technical
Information Technologies
Mobile RheoCardioMonitor
Bauman Moscow State Technical University

2. Problem
 Need to monitor cardiac function indices
 Medical treatment = check for drug dose
 Detection of negative trends
2

3. Solution
 Mobile RheoCardioMonitor –
1 ECG + 1 ICG + Real-Time analysis
 Future prospects
 More channels (ICG/ECG)
 New functionality
 New algorithms
3

4. Benefits
 High accuracy
 Non-invasive measurement
 Long time physician less monitoring
 Certified and verified predecessor (CE0482)
 US Patents:
 № 5,685,316 filled: Nov. 11,1997 (Cited in: 44)
 № 6,161,038 filled: Dec. 12, 2000 (Cited in: 41)
4

5. Market Situation
 By 2011 –
16 300 outpatients'
clinics
 Sales Projection for
a clinical device:
2014 – 15 pcs.
2015 – 40 pcs.
2016 – 180 pcs.
2017 – 320 pcs.
5
2017 Domestic
Rheographs
Imported Devices
Ultrasound
Investigations
RheoCardioMonitor
(Clinical)
2011 Domestic
Rheographs
Imported Devices
Ultrasound
investigations

6. Competitors (in Russia)
6
Mobility Impedance
Data
Need of
physician to
perform a
measurement
Price
Our System
+ + - *
Rheographs
- + + 32 000 RUR
(«Valenta»)
Holter ECG
monitors
+ - - 74 000 RUR
+software
(«Valenta»)
*Price is not available, as now on the prototype stage

7. Business Model
7
 Main Idea: leasing of devices
 What we can do:
 Academic Investigations
 Prove of Concept
 Prototype Creation
 Certification Issues
 Partnership needed:
 Clinic Investigations
 Production and User Support
 Sales

8. The Team
8
 Technical Consultans
 Cand.Techn.Sc. Timohin D.P.
 Cand.Techn.Sc. Kirpichenko Y.E.
 Advisory Board
 Doct.Techn.Sc., Prof.
Schookin S.I. – Science Advisor
 Cand.Techn.Sc., assоciate prof.
Sergeev I.K. – Production Issues
 Cand.Med.Sc. Maslennikov M.A.
Medical Consultant
 Developers
 Kobelev A.V.
software
 Tihomirov A.N.
algorithms
 Kudashov I.A.
circuit design
 Malakhov A.I.
math. modelling
 Cherkashin M.N.
prod.technology

9. Next Step
Clinical Trials:
We need
Partnership!
9
Bauman Moscow State Technical University
Chair for Medico-Technical Information Technologies
Maxim Cherkashin
PhD Student
Mobile RheoCardioMonitor
Chmn (at) nxt.ru
www.bmt.bmstu.ru

10. ~Time Schedule
A2
 Prototype Creation (min. functionality) – 6
months
 Clinical Trials – 12-18 months
 Certification – 18-24 months
 Documentation and Licensing – 24-30 months

11. Patients with firstly registered diagnose, data for Russia, 2011, by 100 000 citizens:
0,0
100,0
200,0
300,0
400,0
500,0
600,0
700,0
active tuberculosis insular diabetes diseases that are
characterised with
hypertension
malignant neoplasms
Statistics
A1

12. Next Step
Clinical Trials:
We need
Partnership!
Bauman Moscow State Technical University
Chair for Medico-Technical Information Technologies
Maxim Cherkashin
PhD Student
Mobile RheoCardioMonitor
Chmn (at) nxt.ru
www.bmt.bmstu.ru